Sanford Burnham Prebys researchers awarded $6.4M to advance treatment for substance use disorders

Their research has shown promise for tobacco use — now they’re tackling another epidemic

David Brenner named Sanford Burnham Prebys president and CEO

The Board of Directors of Sanford Burnham Prebys is pleased to announce the appointment of David Brenner, M.D., as the Institute’s next president and chief executive officer.

How a single protein could unlock age-related vision loss

Research led by Sanford Burnham Prebys professor Francesca Marassi, Ph.D., is helping to reveal the molecular secrets of macular degeneration, which causes almost 90% of all age-related vision loss.